Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Cancer Reports (Hoboken, N.J.)|October 10, 2023
Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisitedMaher Kurdi, Saleh Baeesa, Fahad Okal, et al.Frontiers in Medicine|December 6, 2021
Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?Riffat Mehboob, Maher Kurdi, Ahmed Bamaga, et al.Journal of Neuromuscular Diseases|February 20, 2025
Inflammatory myopathy with abundant macrophage [IMAM]: Systemic analysis and pathological approach to distinguish it from dermatomyositisAhmed Bamaga, Maher Kurdi, Alaa Alkhotani, et al.Frontiers in Oncology|March 18, 2026
Impact of corticosteroid administration on glioblastoma progression before and after adjuvant treatments: recent updates on contradictory findings and mechanistic interactionsMaher Kurdi, Ali Kabli, Alaa Alkhotani, et al.Oncology Research|June 3, 2024
The interplay mechanism between IDH mutation, MGMT-promoter methylation, and PRMT5 activity in the progression of grade 4 astrocytoma: unraveling the complex triad theoryMaher Kurdi, Alaa Alkhotani, Abdulrahman Sabbagh, et al.Cureus|August 1, 2023
The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 AstrocytomaTaher Halawa, Saleh Baeesa, Motaz M Fadul, et al.Biologics : Targets & Therapy|August 2, 2021
Sensitivity Assessment of Wilms Tumor Gene (<i>WT1</i>) Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with <i>IDH1</i> Mutation and Recurrence IntervalMaher Kurdi, Nadeem Shafique Butt, Saleh Baeesa, et al.Biologics : Targets & Therapy|February 13, 2023
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour MicroenvironmentMaher Kurdi, Nasser Mulla, Yousef Katib, et al.Folia Neuropathologica|February 18, 2025
The crosstalk effect of cancer stem cells in the progression of pediatric medulloblastoma through signaling expression of CD133, CD44, and OCT4 with and without Wnt-b-catenin activationMaher Kurdi, Alaa Alkhotani, Motaz Fadul, et al.Frontiers in Bioscience (Landmark Edition)|October 30, 2024
Mitochondrial DNA Alterations in Glioblastoma and Current Therapeutic TargetsMaher Kurdi, Ahmed Bamaga, Alaa Alkhotani, et al.Pageof 6